The REVAMP trial: key questions remain - Authors' reply.
Saved in:
| Title: | The REVAMP trial: key questions remain - Authors' reply. |
|---|---|
| Authors: | Pasricha SR; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia; Clinical Haematology, The Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. Electronic address: pasricha.s@wehi.edu.au., Moya E; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi., Ataide R; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medicine at the Peter Doherty Institute, The University of Melbourne, Parkville, VIC, Australia., Mzembe G; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi., Harding R; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Phiri K; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi. |
| Source: | Lancet (London, England) [Lancet] 2024 Jan 06; Vol. 403 (10421), pp. 29-30. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38184336 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The REVAMP trial: key questions remain - Authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pasricha+SR%22">Pasricha SR</searchLink>; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia; Clinical Haematology, The Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. Electronic address: pasricha.s@wehi.edu.au.<br /><searchLink fieldCode="AU" term="%22Moya+E%22">Moya E</searchLink>; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi.<br /><searchLink fieldCode="AU" term="%22Ataide+R%22">Ataide R</searchLink>; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medicine at the Peter Doherty Institute, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mzembe+G%22">Mzembe G</searchLink>; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi.<br /><searchLink fieldCode="AU" term="%22Harding+R%22">Harding R</searchLink>; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.<br /><searchLink fieldCode="AU" term="%22Phiri+K%22">Phiri K</searchLink>; Training and Research Unit of Excellence, Blantyre, Malawi; Department of Public Health, School of Public and Global Health, Kamuzu University of Health Sciences, Blantyre, Malawi. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2024 Jan 06; Vol. 403 (10421), pp. 29-30. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38184336 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(23)01915-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 29 Titles: – TitleFull: The REVAMP trial: key questions remain - Authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pasricha SR – PersonEntity: Name: NameFull: Moya E – PersonEntity: Name: NameFull: Ataide R – PersonEntity: Name: NameFull: Mzembe G – PersonEntity: Name: NameFull: Harding R – PersonEntity: Name: NameFull: Phiri K IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 01 Text: 2024 Jan 06 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 403 – Type: issue Value: 10421 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |
